<DOC>
	<DOCNO>NCT01684358</DOCNO>
	<brief_summary>This unblinded , randomize control trial ( RCT ) among woman determine : 1 ) unprotected sex measure prostate-specific antigen ( PSA ) among woman receive contraceptive implant immediately baseline three month follow compare woman receive implant three month follow-up visit .</brief_summary>
	<brief_title>A Trial Effect Sino-implant ( II ) Use Condom Use Among Women Kingston , Jamaica</brief_title>
	<detailed_description>This unblinded , randomize control trial ( RCT ) ass whether use contraceptive implant lead sex unprotected condom , measure detection biological marker exposure semen vaginal fluid , among woman Kingston , Jamaica . Eligible woman non-pregnant , know HIV-positive , 18-44 year age , already use long-acting method contraception , without contraindication implant use , willing use Sino-implant ( II ) . Eligible woman recruit Comprehensive Health Centre Center Excellence ( CHC ) Kingston , Jamaica community . Women give write consent study participation enrol study randomize one two study group : 1 ) `` immediate implant '' insertion 2 ) `` delay implant '' insertion ( i.e. , study participation end three month follow ) . All participant receive safe sex counseling , supply condom , administer baseline questionnaire demographic , reproductive history contraceptive sexual practice . A study clinician perform pelvic examination double-headed vaginal swab collect test prostate-specific antigen ( PSA ) , semen biomarker . Participants ask return follow-up visit schedule 1 3 month enrollment , time another double-headed vaginal swab collect pelvic examination test PSA administer follow-up questionnaire . Participants `` delay implant '' group Sino-implant ( II ) insert 3-month visit still want device . Primary objective : To determine whether frequency PSA detection three month follow high immediate implant group delay implant group .</detailed_description>
	<criteria>Be willing randomize receive implant enrollment visit three month ; Be 1844 year age ; Not know HIVpositive ; Have negative pregnancy test baseline ; Not currently use intrauterine device system , contraceptive implant , injectable contraception ; Not plan start use intrauterine contraceptive device system injectable contraception next three month ; Not surgical sterilization plan next three month ; Not medical contraindication implant use , include lactation within first 6 week postpartum , acute deep venous thrombosis pulmonary embolism , lupus , migraine aura , unexplained vaginal bleeding , current history breast cancer , severe cirrhosis , liver tumor , history stroke , current history ischaemic heart disease ; Be willing return clinic two followup visit next three month ; Be otherwise good candidate study participation base investigator assessment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Prostate-specific antigen</keyword>
	<keyword>Contraceptive implant</keyword>
	<keyword>Biological marker</keyword>
	<keyword>Condoms</keyword>
	<keyword>Women</keyword>
</DOC>